RTsafe

26/02/2026

📢 We are proud to announce that RTsafe and the International Stereotactic Radiosurgery Society (ISRS) have extended their strategic cooperation for another three years.

🌟 This renewal is more than an agreement. 🌟
🌐 It is a strong vote of confidence from ISRS in RTsafe’s independent remote dosimetry services and in our shared mission to uphold the highest standards in stereotactic treatments worldwide.

Under the extended collaboration: RTsafe continues to serve as the independent dosimetric verification partner of the ISRS Certification Program
✔️ Both SRS and SBRT Certification pathways are fully supported.
✔️ Treatment centers worldwide benefit from objective, third-party quality assurance.
✔️ The continuation of this partnership reflects the trust built over the past years — trust in scientific rigor, accuracy, reliability, and transparency.

Together with ISRS, we remain committed to strengthening global standards, supporting clinical excellence, and safeguarding patient treatments through independent verification.

🙏 We thank ISRS for their continued confidence and look forward to the years ahead.

19/02/2026

🚀We are proud to share an important milestone for RTsafe!

📢On February 4, 2026, our core innovation, PseudoPatient®, received official Medical Device Marketing Authorization (MDMA-2-2026-0352) from the Saudi Food & Drug Authority (SFDA).

🌐The authorization allows RTsafe to market PseudoPatient in the Kingdom of Saudi Arabia.
📌This achievement follows our prior U.S. FDA 510(k) clearance and further reinforces the safety, robustness, and clinical value of true end-to-end patient-specific radiotherapy verification.
📌The SFDA approval enables comprehensive patient-specific pre-radiotherapeutic end-to-end verification across advanced radiotherapy workflows
Saudi Arabia’s healthcare transformation under Vision 2030 is driving significant investment in oncology and advanced radiotherapy technologies.

🌟We are excited to support leading cancer centers across the Kingdom with solutions that strengthen quality assurance, enhance treatment confidence, and ultimately improve patient safety.

🙏We would like to sincerely thank Welcome Health Ventures for their strategic regulatory guidance throughout this process. Special thanks to Steve Moore for his leadership and expertise in helping us reach this milestone.

✅With both U.S. FDA clearance and Saudi FDA authorization in place, RTsafe continues to expand its global regulatory footprint and bring next-generation end-to-end verification solutions to new markets.

We look forward to collaborating with partners and healthcare providers across the Kingdom of Saudi Arabia.

🔎Press here to read more👉https://rt-safe.com/rtsafes-pseudopatient-receives-saudi-fda-authorization-expanding-access-to-advanced-radiotherapy-qa-across-the-kingdom/

12/02/2026

🎯Han et al. (2019) demonstrate how RTsafe’s PRIME phantom enables rigorous end-to-end validation of motion management and plan adaptation on the Leksell Gamma Knife Icon, supporting safe and accurate delivery of modern stereotactic radiosurgery.
🎯Across 13 challenging motion and set-up scenarios, including near-threshold displacements, coughing events, treatment interruptions, and pitch errors, the motion management system demonstrated reliable dosimetric and geometric accuracy.
✔️Combined with , this study underscores the importance of controlled end-to-end validation for motion-sensitive SRS treatments.

🔎Press to read the article 👉 https://pubmed.ncbi.nlm.nih.gov/31998542/

Our results indicated that dosimetric accuracy of the Gamma Knife® IconTM system is reliable even in extreme treatment conditions. However, the user should exercise caution for superiorly located small lesions with an HDMM threshold ≥2 mm or in the scenario of large initial setup error...

04/02/2026

🌟 February 4 is

🎗️ We stand together in the fight for a cancer-free future.

This month, we’re dedicated to raising awareness about cancer care and highlighting the vital role each of us plays in the battle against cancer.

02/02/2026

Honored to have the RTsafe – Icon Group collaboration recognized by the Australian Private Hospitals Association.

Industry acknowledgment at this level highlights how critical advanced QA solutions are in supporting safe, precise radiosurgery across Australia.

A big thank you to the Australian Private Hospitals Association and Icon Group for helping move the field forward.

30/01/2026

🚀 We invite you to meet our partners, RT-IDea International B.V., Joos Wisse, and Caroline Save, at BHPA 2026!

🎯 Visit them to explore RTsafe’s products and services and see how they can help meet your needs.

29/01/2026

📢 BRSS has officially kicked off!!

🚀 We are excited to be in Manchester and can't wait to meet you and inform you about our new products, services, and collaborations.

👉 Find RTsafe at Oncology Systems Limited’s booth and meet our team, Vasiliki Margaroni and Aliki Stergiou.

21/01/2026

⏳ There is still time to register for our webinar with Oncology Systems Limited, on 22 January 2026, featuring RTsafe's anthropomorphic phantoms, customised solutions, and independent audits.

🎯 Register here 👉https://osl.uk.com/events/webinar-ensuring-dosimetric-accuracy-in-srs-sbrt-treatments-a-comprehensive-end-to-end-solution-by-rtsafe/

15/01/2026

🚀 The European Federation Of Organizations For Medical Physics - EFOMP newsletter- Winter edition has been published.

🎨 Check out RTsafe’s article titled (p45) – RTsafe Remote Dosimetry Audit Services: Ensuring precision, Building confidence.

🔎 Learn more –https://www.efomp.org/uploads/e5a0f47e-55ec-40de-b2bb-96ef1fc08515/EFOMP%20Newsletter%20Winter%202025-1.pdf

08/01/2026

🥁 We are delighted to announce that RTsafe is exhibiting at the 10th Annual Meeting of BRSS!

🌟 We are looking forward to meeting and talking with you about RTsafe’s Dosimetry Audit services and our upcoming solutions for quality assurance in radiation oncology.

🌐 The annual meeting of BRSS will take place on January 29 – 30, 2026, in Manchester.

🔎 Find us at our distributor Oncology Systems Limited's booth!
Learn more about RTsafe’s presence in BRSS 2026 here 👉https://rt-safe.com/rtsafe-to-exhibit-at-brss-10th-annual-meeting-in-manchester/

22/12/2025

🌟 We are sending you our best wishes for a happy holiday season and our sincere thanks for your support this year!

🌟 Wishing you and your loved one Season’s Greetings and all the best in the coming year!

15/12/2025

🚀Icon Group adopts first-to-market RTsafe solutions to support advanced stereotactic radiosurgery across Australia🚀

🌐 “Our collaboration with Icon reflects a shared ambition to continually elevate the standards of cancer care,” said Evangelos Pappas, Founder and CSO of RTsafe. “At RTsafe, our goal is to bring certainty to radiotherapy—giving clinicians robust, independent evidence that complex treatments are delivered as intended, and giving patients peace of mind that their safety is carefully safeguarded at every step.”

🎯 A collaboration that sets a new benchmark for end-to-end quality assurance in cancer care.

🔎 Read the full story👉https://rt-safe.com/icon-group-adopts-first-to-market-rtsafe-solutions-to-support-advanced-radiosurgery-across-australia/